AERONOSE
LIVE

Serial Number

79354820

Owner

APTAR FRANCE SAS

Attorney

Ben Natter

Filing Date

Jul 4, 2022

Add to watchlist:

No watchlists yet
View on USPTO

AERONOSE Trademark

Serial Number: 79354820 • Registration: 7561348

AERONOSE is a trademark filed by APTAR FRANCE SAS on July 4, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 7 (Machinery), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

APTAR FRANCE SAS (45 trademarks)

LE NEUBOURG 27110 , FR

Entity Type: 99

Université de Tours

60 rue du Plat d'Etain

Entity Type: 99

Trademark Details

Filing Date

July 4, 2022

Registration Date

November 12, 2024

Published for Opposition

November 28, 2023

Goods & Services

Software intended for medical use, namely, downloadable and recorded software for modeling and simulating the human nasal cavity; particle flow monitoring devices, namely, flow cytometers and flow-based analyzers providing particle analysis, detection, and counting for scientific, laboratory, and general research uses; all of the aforementioned goods to be used in connection with medical research and development and design of medical devices

Molding machines, namely, injection plastic molding machines; aerosol capping machines; sprayers, namely, spraying machines

Nasal sprays for medical use; molding materials for surgical use, namely, nasal cast models to replicate the internal cavity of the human nose for surgical purposes; all of the aforementioned goods to be used in connection with medical research and development and design of medical devices

Nasal molding apparatus for medical use, namely, apparatus for creating a mold of a patient’s nose to optimize drug delivery; sprayers for medical use, namely, therapeutic devices for delivering specifically engineered aerosol mixtures for medical benefit; testing apparatus for medical use, namely, medical diagnostic apparatus for testing amount and pathway of drug delivery for nasal, rhinological, laryngeal and oral cavity effect; diagnostic apparatus for medical use, namely, medical diagnostic apparatus for detecting amount and pathway of drug delivery for nasal, rhinological, laryngeal and oral cavity effect; all of the aforementioned goods to be used in connection with medical research and development and design of medical devices

Design and development of devices for medical use; design and development of pharmaceutical products; engineering services in the pharmaceutical field; design of molds

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 13, 2025 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Apr 11, 2025 XXSS
GENERIC MADRID TRANSACTION CREATED
Apr 11, 2025 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 12, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 12, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 12, 2024 R.PR
TTAB RELEASE CASE TO TRADEMARKS
Oct 9, 2024 TMBN
OPPOSITION TERMINATED NO. 999999
Oct 9, 2024 OP.T
OPPOSITION DISMISSED NO. 999999
Oct 9, 2024 OP.D
REFUSAL PROCESSED BY IB
Apr 30, 2024 RFNT
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 29, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 10, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 10, 2024 OPNR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Mar 29, 2024 ETOP
OPPOSITION INSTITUTED NO. 999999
Mar 29, 2024 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Mar 28, 2024 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Mar 28, 2024 OPNC
EXTENSION OF TIME TO OPPOSE RECEIVED
Dec 28, 2023 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 28, 2023 NPUB
PUBLISHED FOR OPPOSITION
Nov 28, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Nov 27, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 8, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 8, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 8, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 22, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 20, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 20, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 20, 2023 TROA
REFUSAL PROCESSED BY IB
Jun 6, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 12, 2023 RFCS
REFUSAL PROCESSED BY MPU
May 12, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 23, 2023 RFCR
NON-FINAL ACTION WRITTEN
Mar 22, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 20, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 18, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 14, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 10, 2022 REPR